Selection and prioritization of candidate combination regimens for the treatment of tuberculosis.
Europe PMC REST API · 學術索引收錄 · 來源發佈：Wed Feb 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:07:53 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
Accelerated tuberculosis drug discovery has increased the number of plausible multidrug regimens. Testing every drug combination in vivo is impractical, and varied experimental conditions make it challenging to compare results between experiments. Using published treatment efficacy data from a mouse tuberculosis model treated with candidate combination regimens, we trained and externally validated
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。